Atrial fibrillation is the most common sustained heart rhythm disorder and a leading cause of stroke. Specialized care from a cardiac electrophysiologist meaningfully changes outcomes, medication choice, ablation timing, and stroke prevention all benefit from EP-specific expertise.
Opening June 2026
The Advanced Cardiovascular Institute at the Texas Medical Center, at 6624 Fannin St, Houston, TX 77030, opens in June 2026, our new ambulatory surgery center for cardiac electrophysiology. It will perform catheter ablation, pacemaker, ICD, and loop recorder procedures in the Texas Medical Center for the comfort and convenience of our patients.
Consultations and follow-up continue at our Hargrave Rd clinic in Northwest Houston, with procedures performed at the most appropriate location: Houston Methodist Willowbrook, Houston Methodist Cypress, Baylor St. Luke’s Medical Center, St. Luke’s The Vintage, Memorial Hermann Memorial City, or the new TMC ASC. Learn more → or call (832) 478-5067 to schedule.
Atrial fibrillation (AFib, AF) is an irregular rhythm that originates in the upper chambers of the heart (the atria). Instead of contracting in a coordinated way, the atria fire chaotically, producing an irregular and often rapid ventricular rate.
Three patterns are recognized:
The earlier AFib is identified and treated, the better the long-term outcome. There is growing evidence that early rhythm control, particularly with ablation in selected patients, reduces long-term cardiovascular events.
AFib symptoms vary widely. Some patients describe an unmistakable "fluttering" or "racing" feeling in the chest. Others feel fatigue, shortness of breath, decreased exercise tolerance, or simply a sense that something is off. A meaningful number of patients have no symptoms at all and discover AFib only on a routine ECG or wearable recording.
Symptoms that should prompt evaluation:
For more detail, see our patient-education entry on atrial fibrillation.
The gold standard is a recording. A 12-lead ECG taken during an episode is diagnostic. For paroxysmal patients whose episodes are brief or infrequent, an ambulatory monitor is the next step:
The diagnostic workup also includes an echocardiogram to assess heart structure, a thyroid panel (hyperthyroidism is a treatable AFib trigger), and screening for sleep apnea, one of the most underdiagnosed and most modifiable AFib triggers.
AFib treatment has three goals: prevent stroke, control symptoms, and restore normal rhythm when appropriate.
Risk-stratified using CHA2DS2-VASc score. Most patients above a threshold benefit from a direct oral anticoagulant (apixaban, rivaroxaban, dabigatran, edoxaban) or warfarin. Patients who can't tolerate long-term anticoagulation may be candidates for WATCHMAN left atrial appendage closure.
Beta-blockers, calcium channel blockers, and (in selected cases) digoxin. The goal is a controlled ventricular rate that doesn't cause symptoms. Many older patients with permanent AFib are managed primarily with rate control.
Antiarrhythmic medications (flecainide, propafenone, sotalol, dronedarone, dofetilide, amiodarone) reduce AFib burden. Each has specific indications and side-effect profiles. We tailor the choice to your underlying heart structure, kidney function, and other medications.
Catheter ablation is increasingly the preferred rhythm-control strategy for symptomatic patients, particularly those with paroxysmal AFib, younger patients, and those who tolerate antiarrhythmics poorly. Modern energy sources include pulsed-field (PFA), radiofrequency (RF), and cryoballoon.
Weight loss, sleep apnea treatment, alcohol moderation, blood pressure control, and exercise meaningfully reduce AFib burden in many patients, sometimes enough to defer or avoid further intervention.
A general cardiologist can manage uncomplicated AFib well. An electrophysiologist becomes important when:
The earlier in the disease course the EP is involved, the more treatment options are available, particularly for ablation, where success rates are higher in paroxysmal disease than in long-standing persistent.
Atrial fibrillation is treated by cardiologists and, for advanced or procedural management, by cardiac electrophysiologists (EPs). General cardiologists can manage uncomplicated AFib well; an EP becomes essential when ablation, advanced antiarrhythmics, WATCHMAN, or complex disease is involved.
If your AFib is well-controlled on medications and you're not considering ablation or LAA closure, a general cardiologist is reasonable. An EP is recommended when ablation is being considered, when antiarrhythmics are being chosen or monitored, when WATCHMAN is on the table, when the diagnosis is atypical, or when AFib coexists with structural heart disease.
AFib is diagnosed with an electrocardiogram (ECG) showing the characteristic irregular rhythm without P waves. For patients with intermittent symptoms, ambulatory monitoring is used, Holter (1-2 days), patch (14-30 days), mobile cardiac telemetry, or an implantable loop recorder for infrequent episodes. The workup also includes echocardiogram and thyroid testing.
AFib cannot always be cured outright, but catheter ablation can produce long-term freedom from AFib in many patients, particularly those with paroxysmal AFib treated early in the disease course. Persistent and long-standing persistent AFib are harder to treat curatively and often require lifestyle changes and ongoing medical therapy alongside any procedure.
Modern AFib ablation is performed routinely and has a strong safety record. Serious complications occur in 1-3% of cases at experienced centers. Pulsed-field ablation has further reduced certain rare complications (esophageal injury, phrenic nerve injury) compared to traditional thermal energy. Discuss your specific risk profile with the EP performing the procedure.
New patients seen within one week for urgent concerns.
Clinic: 13325 Hargrave Rd, Suite 280, Houston, TX 77070 · Mon-Fri 8:30 AM – 5:00 PM
Opening June 2026: Advanced Cardiovascular Institute at the Texas Medical Center · 6624 Fannin St, Houston, TX 77030
Call (832) 478-5067